Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma —a proof of concept study
ConclusionThis study highlights the potential of hu3F8-based alpha-particle therapy as a promising treatment strategy for OS.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Bone Cancers | MRI Scan | Nuclear Medicine | Osteosarcoma | Study | Toxicology | Urology & Nephrology